z-logo
open-access-imgOpen Access
Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment
Author(s) -
Gozde HasbalCelikok,
Pinar AksoySagirli,
Gulsum AltiparmakUlbegi,
Ayşe Can
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12470
Subject(s) - cetuximab , kras , colorectal cancer , oxaliplatin , cancer research , irinotecan , cancer , drug resistance , akt1 , medicine , biology , apoptosis , genetics , pi3k/akt/mtor pathway

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here